Brokerages Set Travere Therapeutics, Inc. (NASDAQ:TVTX) Target Price at $17.85

Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the fifteen analysts that are presently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average […]

Related Keywords

China ,Peter Heerma ,Piper Sandler ,Christopherr Cline ,Zurcher Kantonalbank Zurich Cantonalbank ,Nasdaq ,Wells Fargo Company ,Dynamic Technology Lab Private Ltd ,Nisa Investment Advisors ,Securities Exchange Commission ,Travere Therapeutics Company Profile ,China Universal Asset Management Co ,Travere Therapeutics Inc ,Travere Therapeutics ,Get Free Report ,Exchange Commission ,Investment Advisors ,Universal Asset Management ,Technology Lab Private Ltd ,Kantonalbank Zurich Cantonalbank ,Get Free ,Iga Nephropathy ,Travere Therapeutics Daily ,